Newmont stock ends 2025 lower as gold cools — CEO handoff kicks off 2026 focus
1 January 2026
1 min read

Newmont stock ends 2025 lower as gold cools — CEO handoff kicks off 2026 focus

NEW YORK, January 1, 2026, 17:12 ET — Market closed

  • Newmont shares ended the final trading day of 2025 down about 2% at $99.85. 1
  • The gold miner starts 2026 with a new CEO as investors track bullion’s volatile year-end tape. 2
  • Traders are watching gold prices, U.S. rate signals and the next earnings window for fresh direction. 3

Newmont Corporation shares closed down 1.97% at $99.85 on Wednesday, the last trading day of 2025, with U.S. markets shut on Thursday for the New Year’s Day holiday. 1

The move matters because gold miners often magnify swings in bullion: costs are relatively fixed in the short run, so small changes in gold prices can quickly change expected cash generation.

Newmont also begins 2026 with a leadership transition. The company said President and COO Natascha Viljoen became CEO on Jan. 1, joining the board, after Tom Palmer stepped down at year-end and moved into a strategic adviser role through March 31. 2

Gold prices were choppy into year-end after a historic run. Spot gold rose 0.8% to $4,364.70 an ounce on Dec. 30 after profit-taking pushed it down from a record $4,549.71, Reuters reported. 4

Risk appetite also faded late in the week. The S&P 500 fell 0.74% in the final session of 2025, with the Nasdaq down 0.76% and the Dow off 0.63%, Reuters said. 5

Precious-metals shares moved with the tape. Barron’s said silver slid after CME raised margin requirements — the cash collateral traders must post to hold futures positions — and miners tracked the drop. 6

Newmont traded between $99.72 and $101.44 on Wednesday and finished with about 5.4 million shares changing hands, according to Yahoo Finance data. 7

Even with the late dip, Newmont’s stock booked a roughly 173% gain in 2025, leaving it exposed to profit-taking when bullion softens and equity investors de-risk into the turn of the year. 8

The CEO handoff adds another variable. In outlining her priorities, Viljoen said the company would focus on “cost discipline” and “judicious capital allocation,” according to Newmont’s succession announcement. 2

Before next session: Traders will be looking for steadier signals from gold and rate markets when U.S. trading resumes on Friday, with Newmont sitting near the psychologically important $100 level after the year-end slide.

The Federal Reserve’s 2026 calendar shows its next two-day policy meeting is scheduled for Jan. 27-28, with minutes from that meeting due Feb. 18. 3

The next major U.S. labor-market catalyst on the calendar is the Employment Situation report for December 2025, scheduled for Jan. 9 at 8:30 a.m. ET, according to the Bureau of Labor Statistics. 9

On the company calendar, Newmont has not posted a firm date for its next earnings report, but Zacks lists Feb. 19 as the expected timing. The stock ended 2025 below its 52-week high of $106.34 and above its 52-week low of $37.68, according to Investing.com data — levels chart-focused traders often treat as markers for momentum and support. 10

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
S&P Global (SPGI) stock ends 2025 down nearly 1% as markets shut for New Year’s — what to watch next
Previous Story

S&P Global (SPGI) stock ends 2025 down nearly 1% as markets shut for New Year’s — what to watch next

Morgan Stanley stock ends 2025 lower as Wall Street shuts for New Year’s Day — what investors watch next
Next Story

Morgan Stanley stock ends 2025 lower as Wall Street shuts for New Year’s Day — what investors watch next

Go toTop